Commentary: Guideline for male testosterone therapy: A European perspective

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 2, 2007, Pages 418-419

  Wu, Frederick C W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

AGE DISTRIBUTION; ALGORITHM; ANDROGEN DEFICIENCY; ANDROPAUSE; CLINICAL DECISION MAKING; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; TESTOSTERONE BLOOD LEVEL;

EID: 33846952171     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2799     Document Type: Note

References (10)

1. Liu PY, Swerdloff RS, Veldhuis JD 2004 The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89:4789-4796
2. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC 2005 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28:125-127
3. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91:1995-2010
4. Liverman CT, Blazer DG 2004 Testosterone and aging clinical research directions. Washington, DC: Institute of Medicine of the National Academies
5. Handelsman DJ 2004 Trends and regional differences in testosterone prescribing in Australia, 1991-2001. Med J Aust 181:419-422
6. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876
7. Arnott J, A clinically relevant approach to defining the prevalence of late-onset hypogonadism in men from the general population. Program of the 88th Annual Meeting of The Endocrine Society, Boston, MA, 2006 (Abstract OR5-4)
8. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB 2005 Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 62:64-73
9. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S 2005 Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451-1457
10. Bhasin S, Wu F 2006 Making a diagnosis of androgen deficiency in adult men: what to do until all the facts are in? Nat Clin Pract Endocrinol Metab 2:529